References
- Casey JR, Kaur R, Friedel VC, Pichichero ME. Acute otitis media otopathogens during 2008 to 2010 in Rochester, New York. Pediatr Infect Dis J. 2013;32:805–09.
- Casey JR, Pichichero ME. Changes in frequency and pathogens causing acute otitis media in 1995–2003. Pediatr Infect Dis J. 2004;23:824–28. doi:https://doi.org/10.1097/01.inf.0000136871.51792.19.
- Pichichero ME, Pichichero CL. Persistent acute otitis media: I. Causative pathogens. Pediatr Infect Dis J. 1995;14:178–83. doi:https://doi.org/10.1097/00006454-199503000-00002.
- Casey JR, Kauer R, Pichichero M Otopathogens causing otitis media in the 13-valent pneumococcal conjugate vaccine era. 18th international symposium on recent advances in otitis media. Gaylord National Resort and Convention Center, Maryland, USA; 2015. p. 211.
- Sillanpaa S, Oikarinen S, Sipila M, Kramna L, Rautiainen M, Huhtala H, Aittoniemi J, Laranne J, Hyöty H, Cinek O, et al. Moraxella catarrhalis might be more common than expected in acute otitis media in young finnish children. J Clin Microbiol. 2016;54(9):2373–79. doi:https://doi.org/10.1128/JCM.01146-16.
- Revai K, McCormick DP, Patel J, Grady JJ, Saeed K, Chonmaitree T. Effect of pneumococcal conjugate vaccine on nasopharyngeal bacterial colonization during acute otitis media. Pediatrics. 2006;117:1823–29. doi:https://doi.org/10.1542/peds.2005-1983.
- Monasta L, Ronfani L, Marchetti F, Montico M, Vecchi Brumatti L, Bavcar A, Grasso D, Barbiero C, Tamburlini G. Burden of disease caused by otitis media: systematic review and global estimates. PLoS One. 2012;7(4):e36226. doi:https://doi.org/10.1371/journal.pone.0036226.
- Kaplan B, Wandstrat TL, Cunningham JR. Overall cost in the treatment of otitis media. Pediatr Infect Dis J. 1997;16:S9–11. doi:https://doi.org/10.1097/00006454-199702001-00003.
- Murphy TF, Brauer AL, Grant BJ, Sethi S. Moraxella catarrhalis in chronic obstructive pulmonary disease: burden of disease and immune response. Am J Respir Crit Care Med. 2005;172:195–99. doi:https://doi.org/10.1164/rccm.200412-1747OC.
- Seemungal TA, Hurst JR, Wedzicha JA. Exacerbation rate, health status and mortality in COPD–a review of potential interventions. Int J Chron Obstruct Pulmon Dis. 2009;4:203–23. doi:https://doi.org/10.2147/COPD.S3385.
- Jones MM, Johnson A, Koszelak-Rosenblum M, Kirkham C, Brauer AL, Malkowski MG, Murphy TF. Role of the oligopeptide permease ABC transporter of Moraxella catarrhalis in nutrient acquisition and persistence in the respiratory tract. Infect Immun. 2014;82:4758–66. doi:https://doi.org/10.1128/IAI.02185-14.
- Su YC, Singh B, Riesbeck K. Moraxella catarrhalis: from interactions with the host immune system to vaccine development. Future Microbiol. 2012;7:1073–100. doi:https://doi.org/10.2217/fmb.12.80.
- Mawas F, Ho MM, Corbel MJ. Current progress with Moraxella catarrhalis antigens as vaccine candidates. Expert Rev Vaccines. 2009;8:77–90. doi:https://doi.org/10.1586/14760584.8.1.77.
- Tan TT, Riesbeck K. Current progress of adhesins as vaccine candidates for Moraxella catarrhalis. Expert Rev Vaccines. 2007;6:949–56. doi:https://doi.org/10.1586/14760584.6.6.949.
- Ren D, Pichichero ME. Vaccine targets against Moraxella catarrhalis. Expert Opin Ther Targets. 2016;20:19–33. doi:https://doi.org/10.1517/14728222.2015.1081686.
- Smidt M, Battig P, Verhaegh SJ, Niebisch A, Hanner M, Selak S, Schüler W, Morfeldt E, Hellberg C, Nagy E, et al. Comprehensive antigen screening identifies Moraxella catarrhalis proteins that induce protection in a mouse pulmonary clearance model. PLoS One. 2013;8:e64422. doi:https://doi.org/10.1371/journal.pone.0064422.
- Verhaegh SJ, de Vogel CP, Riesbeck K, Lafontaine ER, Murphy TF, Verbrugh HA, Jaddoe VWV, Hofman A, Moll HA, van Belkum A, et al. Temporal development of the humoral immune response to surface antigens of Moraxella catarrhalis in young infants. Vaccine. 2011;29(34):5603–10. doi:https://doi.org/10.1016/j.vaccine.2011.06.019.
- LaFontaine ER, Snipes LE, Bullard B, Brauer AL, Sethi S, Murphy TF. Identification of domains of the Hag/MID surface protein recognized by systemic and mucosal antibodies in adults with chronic obstructive pulmonary disease following clearance of Moraxella catarrhalis. Clin Vaccine Immunol. 2009;16:653–59. doi:https://doi.org/10.1128/CVI.00460-08.
- Murphy TF, Kirkham C, Liu DF, Sethi S. Human immune response to outer membrane protein CD of Moraxella catarrhalis in adults with chronic obstructive pulmonary disease. Infect Immun. 2003;71:1288–94. doi:https://doi.org/10.1128/IAI.71.3.1288-1294.2003.
- Luke-Marshall NR, Sauberan SL, Campagnari AA. Comparative analyses of the Moraxella catarrhalis type-IV pilus structural subunit PilA. Gene. 2011;477:19–23. doi:https://doi.org/10.1016/j.gene.2011.01.010.
- Ruckdeschel EA, Kirkham C, Lesse AJ, Hu Z, Murphy TF. Mining the Moraxella catarrhalis genome: identification of potential vaccine antigens expressed during human infection. Infect Immun. 2008;76:1599–607. doi:https://doi.org/10.1128/IAI.01253-07.
- Ren D, Almudevar AL, Murphy TF, Lafontaine ER, Campagnari AA, Luke-Marshall N, Casey JR, Pichichero ME. Serum antibody response to Moraxella catarrhalis proteins OMP CD, OppA, Msp22, Hag, and PilA2 after nasopharyngeal colonization and acute otitis media in children. Vaccine. 2015;33:5809–14. doi:https://doi.org/10.1016/j.vaccine.2015.09.023.
- Ren D, Murphy TF, Lafontaine ER, Pichichero ME. Stringently defined otitis prone children demonstrate deficient naturally induced mucosal antibody response to Moraxella catarrhalis proteins. Front Immunol. 2017;8:953. doi:https://doi.org/10.3389/fimmu.2017.00953.
- Ren D, Almudevar AL, Murphy TF, Lafontaine ER, Campagnari AA, Luke-Marshall N, Pichichero ME. Serum antibody response to Moraxella catarrhalis proteins in stringently defined otitis prone children. Vaccine. 2019;37:4637–45. doi:https://doi.org/10.1016/j.vaccine.2017.07.027.
- Pichichero ME. Booster vaccinations: can immunologic memory outpace disease pathogenesis? Pediatrics. 2009;124:1633–41. doi:https://doi.org/10.1542/peds.2008-3645.
- Pichichero ME, Casey JR, Almudevar A. Reducing the frequency of acute otitis media by individualized care. Pediatr Infect Dis J. 2013;32:473–78. doi:https://doi.org/10.1097/INF.0b013e3182862b57.
- Pichichero ME. Ten-year study of the stringently defined otitis-prone child in Rochester, NY. Pediatr Infect Dis J. 2016;35:1033–39. doi:https://doi.org/10.1097/INF.0000000000001217.
- Kaur R, Casey JR, Pichichero ME. Serum antibody response to three non-typeable Haemophilus influenzae outer membrane proteins during acute otitis media and nasopharyngeal colonization in otitis prone and non-otitis prone children. Vaccine. 2011;29:1023–28. doi:https://doi.org/10.1016/j.vaccine.2010.11.055.
- Sharma SK, Casey JR, Pichichero ME. Reduced memory CD4+ T-cell generation in the circulation of young children may contribute to the otitis-prone condition. J Infect Dis. 2011;204:645–53. doi:https://doi.org/10.1093/infdis/jir340.
- Sharma SK, Casey JR, Pichichero ME. Reduced serum IgG responses to pneumococcal antigens in otitis-prone children may be due to poor memory B-cell generation. J Infect Dis. 2012;205:1225–29. doi:https://doi.org/10.1093/infdis/jis179.
- Pichichero ME. New combination vaccines. Pediatr Clin North Am. 2000;47:407–26. doi:https://doi.org/10.1016/S0031-3955(05)70214-5.
- Ren D, Almudevar AL, Pichichero ME. Synchrony in serum antibody response to conserved proteins of Streptococcus pneumoniae in young children. Hum Vaccin Immunother. 2015;11:489–97. doi:https://doi.org/10.4161/21645515.2014.990861.
- Pichichero ME, Kaur R, Casey JR, Sabirov A, Khan MN, Almudevar A. Antibody response to Haemophilus influenzae outer membrane protein D, P6, and OMP26 after nasopharyngeal colonization and acute otitis media in children. Vaccine. 2010;28:7184–92. doi:https://doi.org/10.1016/j.vaccine.2010.08.063.
- Pichichero ME, Kaur R, Casey JR, Xu Q, Almudevar A, Ochs M. Antibody response to Streptococcus pneumoniae proteins PhtD, LytB, PcpA, PhtE and Ply after nasopharyngeal colonization and acute otitis media in children. Hum Vaccin Immunother. 2012;8:799–805. doi:https://doi.org/10.4161/hv.19820.
- Xu Q, Casey JR, Newman E, Pichichero ME. Otitis-prone children have immunologic deficiencies in naturally acquired nasopharyngeal mucosal antibody response after streptococcus pneumoniae colonization. Pediatr Infect Dis J. 2016;35:54–60. doi:https://doi.org/10.1097/INF.0000000000000949.
- Ren D, Xu Q, Almudevar AL, Pichichero ME. Impaired proinflammatory response in stringently defined otitis-prone children during viral upper respiratory infections. Clin Infect Dis. 2019;68:1566–74. doi:https://doi.org/10.1093/cid/ciy750.
- Fitzmaurice GM, Laird NM, Ware JH. Applied longitudinal analysis. New Jersey, USA: Wiley; 2011.
- Pinheiro JC, Bates DM. Mixed effects models in S and S-Plus. New York, NY: Springer-Verlag; 2000.
- Bates D, Mächler M, Bolker BM, Walker SC. Fitting linear mixed-effects models using lme4. J Stat Softw. 2015;67:1–48. doi:https://doi.org/10.18637/jss.v067.i01.
- Kaur R, Casey JR, Pichichero ME. Serum antibody response to five Streptococcus pneumoniae proteins during acute otitis media in otitis-prone and non-otitis-prone children. Pediatr Infect Dis J. 2011;30:645–50. doi:https://doi.org/10.1097/INF.0b013e31821c2d8b.